2-acetylaminofluorene has been researched along with Biliary Tract Diseases in 2 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Biliary Tract Diseases: Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bladder cancer was also present in rats administered the sequence of FANFT, 2-FAA, and 3,3'-DCB." | 1.26 | Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats. ( Hananouchi, M; Hirose, M; Miyata, Y; Mizutani, M; Tatematsu, M, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tatematsu, M | 2 |
| Miyata, Y | 1 |
| Mizutani, M | 1 |
| Hananouchi, M | 1 |
| Hirose, M | 1 |
| Kaku, T | 1 |
| Medline, A | 1 |
| Farber, E | 1 |
2 other studies available for 2-acetylaminofluorene and Biliary Tract Diseases
| Article | Year |
|---|---|
Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
Topics: 2-Acetylaminofluorene; 3,3'-Dichlorobenzidine; Animals; Benzidines; Biliary Tract Diseases; Butylhyd | 1977 |
Intestinal metaplasia as a common option of oval cells in relation to cholangiofibrosis in liver of rats exposed to 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Animals; Autoradiography; Biliary Tract Diseases; gamma-Glutamyltransferase; | 1985 |